Consolidated Statement Of Comprehensive Income

Carna Biosciences, Inc. - Filing #7571400

Concept 2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
Consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
-1,405,357,000 JPY
-1,405,357,000 JPY
-1,349,539,000 JPY
-1,405,357,000 JPY
-1,405,357,000 JPY
-556,425,000 JPY
-556,425,000 JPY
-556,425,000 JPY
-556,425,000 JPY
-534,474,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
-1,742,000 JPY
-652,000 JPY
Deferred gains or losses on hedges
-5,962,000 JPY
7,754,000 JPY
Foreign currency translation adjustment
25,384,000 JPY
16,396,000 JPY
Other comprehensive income
17,678,000 JPY
23,498,000 JPY
Comprehensive income
-1,331,861,000 JPY
-510,976,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
-1,331,861,000 JPY
-510,976,000 JPY
Comprehensive income attributable to non-controlling interests
JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.